drugset / Trial / NCT03490786
A Dose Escalating Study to Assess the Safety and Tolerability of GT-001
NaSingle-groupOpen-labelTreatment
Summary
Dose escalation study of GT-001
Timeline
- Start
- 2017-07-16
- Primary completion
- 2017-08-09
- Completion
- 2017-10-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PEPTIDE YY HUMAN (3-36) | Peptide | 2.5 mg | Topical |